Trial reportAmerican journal of preventive medicine2012
Family history assessment: impact on disease risk perceptions.
Trial report in American journal of preventive medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis.JCO clinical cancer informatics · 2021Pooled it
- Effect of interventions including provision of personalised cancer risk information on accuracy of risk perception and psychological responses: A systematic review and meta-analysis.Patient education and counseling · 2020Pooled it
- Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes.The British journal of general practice : the journal of the Royal College of General Practitioners · 2019Pooled it
- Cancer risk assessment tools in primary care: a systematic review of randomized controlled trials.Annals of family medicine · 2015Pooled it
- The Effects of Personalizing Colorectal Cancer Risk Communication on Risk Perceptions and Health Behavior Intentions: a Randomized Trial of Average-Risk Adults.Journal of cancer education : the official journal of the American Association for Cancer Education · 2021Trial
- A randomised controlled trial of the effect of providing online risk information and lifestyle advice for the most common preventable cancers: study protocol.BMC public health · 2018Trial
- User Perceptions and Reactions to an Online Cancer Risk Assessment Tool: a Process Evaluation of Cancer Risk Check.Journal of cancer education : the official journal of the American Association for Cancer Education · 2017Trial
- A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care.American journal of preventive medicine · 2017Trial
- Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr).Preventive medicine · 2015Trial
- Using web-based familial risk information for diabetes prevention: a randomized controlled trial.BMC public health · 2013Trial
- Family history of premature CHD and risk factor control in patients with a recent ACS.NPJ cardiovascular health · 2025Article
- Diabetes mellitus risk in post-myocardial infarction patients: FINDRISC versus self-assessment-a cross sectional study.Cardiovascular diabetology · 2025Article
- A qualitative study of perceptions of control over potential causes of death and the sources of information that inform perceptions of risk.Health psychology and behavioral medicine · 2022Article
- Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review.Journal of community genetics · 2020Article
- Measurement and Outcomes of the Perceived Risk of Stroke: A Review.Western journal of nursing research · 2019Review
- Development and Validation of Lifestyle-Based Models to Predict Incidence of the Most Common Potentially Preventable Cancers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019Article
- Risk accuracy of type 2 diabetes in middle aged adults: Associations with sociodemographic, clinical, psychological and behavioural factors.Patient education and counseling · 2018Article
- Responses to provision of personalised cancer risk information: a qualitative interview study with members of the public.BMC public health · 2017Article
- How best to protect the vital interests of donor-conceived individuals: prohibiting or mandating anonymity in gamete donations?Reproductive biomedicine & society online · 2016Article
- Cancer Worry, Perceived Risk and Cancer Screening in First-Degree Relatives of Patients with Familial Gastric Cancer.Journal of genetic counseling · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundFamily Healthware™, a tool developed by the CDC, is a self-administered web-based family history tool that assesses familial risk for six diseases (coronary heart disease; stroke; diabetes; and colon, breast, and ovarian cancers) and provides personalized prevention messages based on risk. The Family Healthware Impact Trial (FHITr) set out to examine the clinical utility of presenting personalized preventive messages tailored to family history risk for improving health behaviors. PURPOSE: The purpose of this study was to examine the impact of Family Healthware on modifying disease risk perceptions, particularly among those who initially underestimated their risk for certain diseases.
designA total of 3786 patients were enrolled in a cluster-randomized trial to evaluate the clinical utility of Family Healthware. SETTING/
participantsParticipants were recruited from 41 primary care practices among 13 states between 2005 and 2007.
main outcome measuresPerceived risk for each disease was assessed at baseline and 6-month follow-up using a single-item comparative risk question. Analyses were completed in March 2012.
resultsCompared to controls, Family Healthware increased risk perceptions among those who underestimated their risk for heart disease (15% vs 9%, p<0.005); stroke (11% vs 8%, p<0.05); diabetes (18% vs 11%, p<0.05); and colon cancer (17% vs 10%, p=0.05) but not breast or ovarian cancers. The majority of underestimators did not shift in their disease risk perceptions.
conclusionsFamily Healthware was effective at increasing disease risk perceptions, particularly for metabolic conditions, among those who underestimated their risk. Results from this study also demonstrate the relatively resistant nature of risk perceptions.
trial registrationThis study is registered at clinicaltrials.govNCT00164658.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.